Finance News – Merck
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Dow Leads as Merck, Amgen Gain: Stock Market Today
Investors focused on corporate earnings as pharmaceutical and consumer goods companies reported results, influencing market movement and contributing to modest gains across major s...
Read Full Article →Verona Pharma Stock Soars to All-Time High as Merck Buys Firm for $10B
The acquisition of Verona Pharma by Merck for $10 billion has led to a substantial increase in the company's market value, reflecting strong investor confidence and financial growt...
Read Full Article →Verona Pharma Stock Soars to All-Time High as Merck Buys Firm for $10B
The acquisition of Verona Pharma by Merck for $10 billion has significantly increased the company's market value, reflecting strong investor confidence and substantial financial gr...
Read Full Article →Merck dives into COPD treatments with $10 billion purchase of Verona Pharma
The $10 billion acquisition by Merck highlights the growing market potential of COPD therapies and significantly impacts Verona Pharma’s valuation in the pharmaceutical sector.
Read Full Article →RFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants
The approval of Merck’s RSV vaccine by the restructured CDC panel could impact healthcare markets by potentially increasing infant vaccine adoption and influencing related pharmace...
Read Full Article →Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting close...
Pharmaceutical companies are advancing the development of specialized cancer treatments, potentially reducing reliance on chemotherapy and driving significant market growth through...
Read Full Article →Merck Gets FDA Approval to Expand Use of Its Top-Selling Drug, Keytruda
The recent FDA authorization to broaden the application of Merck's leading medication could potentially increase the company's revenue by accessing new patient populations and expa...
Read Full Article →FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...
Read Full Article →